Header
Header
Article

The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database | BMC Gastroenterology


  • Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. https://doi.org/10.1038/nrgastro.2017.109.

    Article 
    PubMed 

    Google Scholar
     

  • Wong RJ, Liu B, Bhuket T. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a crosssectional analysis of 2011–2014 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2017;46:974–80.

    CAS 
    Article 

    Google Scholar
     

  • Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–71. https://doi.org/10.1016/j.jhep.2018.09.014.

    Article 
    PubMed 

    Google Scholar
     

  • Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59(1):160–8. https://doi.org/10.1016/j.jhep.2013.03.007.

    Article 
    PubMed 

    Google Scholar
     

  • Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9(6):524–30. https://doi.org/10.1016/j.cgh.2011.03.020.

    Article 
    PubMed 

    Google Scholar
     

  • Wieland AC, Mettler P, McDermott MT, Crane LA, Cicutto LC, Bambha KM. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol. 2015;49:e6–10.

    CAS 
    Article 

    Google Scholar
     

  • Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011;34:216–9.

    Article 

    Google Scholar
     

  • WHO. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018.


    Google Scholar
     

  • Review for “Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990–2019: estimation based on global burden of disease study 2019”. 2021. https://doi.org/10.1002/hon.2936/v2/review1

  • Ajmera VH, Terrault NA, Harrison SA. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology. 2017;65(6):2090–9. https://doi.org/10.1002/hep.29055.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Moriya A, Iwasaki Y, Ohguchi S, Kayashima E, Mitsumune T, Taniguchi H, Ikeda F, Shiratori Y, Yamamoto K. Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Therap. 2010;33(3):378–88. https://doi.org/10.1111/j.1365-2036.2010.04520.x.

    CAS 
    Article 

    Google Scholar
     

  • Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, Schwimmer JB. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol. 2012;57(2):384–91. https://doi.org/10.1016/j.jhep.2012.03.024.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ajmera V, Belt P, Wilson LA, Gill RM, Loomba R, Kleiner DE, Neuschwander-Tetri BA, Terrault N. Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis. Clin Gastroenterol Hepatol. 2018;16(9):1511–20. https://doi.org/10.1016/j.cgh.2018.01.026.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mehta M, Satsangi S, Duseja A, Taneja S, Dhiman RK, Chawla YK. Can alcoholic liver disease and nonalcoholic fatty liver disease Co-exist? J Clin Exp Hepatol. 2016;6:S27. https://doi.org/10.1016/j.jceh.2016.06.050.

    Article 

    Google Scholar
     

  • Mehta M, Satsangi S, Duseja A, Taneja S, Dhiman RK, Chawla Y. Can alcoholic liver disease and nonalcoholic fatty liver disease co-exist? J Clin Exp Hepatol. 2017;7(2):121–6. https://doi.org/10.1016/j.jceh.2017.01.112.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chamorro A, Torres J, Mirón-Canelo J, González-Sarmiento R, Laso F, Marcos M. Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis. Aliment Pharmacol Therap. 2014;40(6):571–81. https://doi.org/10.1111/apt.12890.

    CAS 
    Article 

    Google Scholar
     

  • Singh A, Dhaliwal AS, Singh S, Kumar A, Lopez R, Gupta M, Noureddin M, Carey W, McCullough A, Alkhouri N. Awareness of nonalcoholic fatty liver disease is increasing but remains very low in a representative US cohort. Dig Dis Sci. 2019;65(4):978–86. https://doi.org/10.1007/s10620-019-05700-9.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Jun DW, Cho YK, Sohn JH, Lee CH, Kim SH, Eun JR. A study of the awareness of chronic liver diseases among Korean adults. Korean J Hepatol. 2011;17(2):99. https://doi.org/10.3350/kjhep.2011.17.2.99.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • National Center for Health Statistics (US). Health, United States, 2018. Hyattsville, MD: National Center for Health Statistics (US); 2019.


    Google Scholar
     

  • Karlas T, Petroff D, Sasso M, Fan J, Mi Y, De Lédinghen V, Kumar M, Lupsor-Platon M, Han K, Cardoso AC, Ferraioli G, Chan W, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart J, Sarin SK, Badea R, Jung KS, Marcellin P, Filice C, Mahadeva S, Wong GL-H, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022–30. https://doi.org/10.1016/j.jhep.2016.12.022.

    Article 
    PubMed 

    Google Scholar
     

  • Fourth national report on human exposure to environmental chemicals. Updated tables, March 2021: volume two: NHANES 2011–2016; 2021. https://doi.org/10.15620/105345

  • Abeysekera KW, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J, Hickman M. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. Lancet Gastroenterol Hepatol. 2020;5(3):295–305. https://doi.org/10.1016/s2468-1253(19)30419-4.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23. https://doi.org/10.1002/hep.25762.

    Article 
    PubMed 

    Google Scholar
     

  • Younossi Z, Henry L. Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality. Gastroenterology. 2016;150(8):1778–85. https://doi.org/10.1053/j.gastro.2016.03.005.

    Article 
    PubMed 

    Google Scholar
     

  • Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Front Med. 2020. https://doi.org/10.3389/fmed.2020.00448.

    Article 

    Google Scholar
     

  • Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep. 2020;2(3):100101. https://doi.org/10.1016/j.jhepr.2020.100101.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Agarwal D. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol Biol (Paris). 2001;49(9):703–9. https://doi.org/10.1016/s0369-8114(01)00242-5.

    CAS 
    Article 

    Google Scholar
     

  • Hasin D, Delker E. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)—a huge resource for data and research findings. Addiction. 2015;110(3):378–80. https://doi.org/10.1111/add.12794.

    Article 
    PubMed 

    Google Scholar
     

  • Williams R, Alexander G, Armstrong I, Baker A, Bhala N, Camps-Walsh G, Cramp ME, Lusignan S, Day N, Dhawan A, Dillon J, Drummond C, Dyson J, Foster G, Gilmore I, Hudson M, Kelly D, Langford A, McDougall N, Meier P, Moriarty K, Newsome P, O’Grady J, Pryke R, Rolfe L, Rice P, Rutter H, Sheron N, Taylor A, Thompson J, Thorburn D, Verne J, Wass J, Yeoman A. Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: Fourth report of the Lancet standing Commission on liver disease in the UK. Lancet. 2018;391(10125):1097–107. https://doi.org/10.1016/s0140-6736(17)32866-0.

    Article 
    PubMed 

    Google Scholar
     

  • Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ. 2010;340:c1240–c1240. https://doi.org/10.1136/bmj.c1240.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ye Y, Kerr WC. Alcohol and liver cirrhosis mortality in the United States: comparison of methods for the analyses of time-series panel data models. Alcohol Clin Exp Res. 2010;35(1):108–15. https://doi.org/10.1111/j.1530-0277.2010.01327.x.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mrad RA, Merjaneh N, Mubarak G, Lopez R, Zein NN, Alkhouri N. The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: a growing epidemic. Hepatology. 2016;64(4):1386–7. https://doi.org/10.1002/hep.28555.

    Article 
    PubMed 

    Google Scholar
     

  • Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS ONE. 2015;10(10):e0140908. https://doi.org/10.1371/journal.pone.0140908.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Stein E, Cruz-Lemini M, Altamirano J, Ndugga N, Couper D, Abraldes JG, Bataller R. Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide. J Hepatol. 2016;65(5):998–1005. https://doi.org/10.1016/j.jhep.2016.06.018.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Sheron N. Alcohol and liver disease in Europe—simple measures have the potential to prevent tens of thousands of premature deaths. J Hepatol. 2016;64(4):957–67. https://doi.org/10.1016/j.jhep.2015.11.006.

    Article 
    PubMed 

    Google Scholar
     

  • Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082–90. https://doi.org/10.1002/hep.24452.

    Article 
    PubMed 

    Google Scholar
     

  • Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, Sung JJ, De Lédinghen V. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2009;51(2):454–62. https://doi.org/10.1002/hep.23312.

    CAS 
    Article 

    Google Scholar
     

  • Foucher J. Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut. 2006;55(3):403–8. https://doi.org/10.1136/gut.2005.069153.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, Duarte-Rojo A, Wong D, Crotty P, Elkashab M. Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 2012;32(6):902–10. https://doi.org/10.1111/j.1478-3231.2012.02781.x.

    Article 
    PubMed 

    Google Scholar
     

  • Siddiqui MS, Idowu MO, Stromberg K, Sima A, Lee E, Patel S, Ghaus S, Driscoll C, Sterling RK, John B, Bhati CS. Diagnostic performance of vibration-controlled transient elastography in liver transplant recipients. Clin Gastroenterol Hepatol. 2021;19(2):367–74. https://doi.org/10.1016/j.cgh.2020.03.067.

    Article 
    PubMed 

    Google Scholar
     

  • Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan W, Yilmaz Y, Czernichow S, Zheng M, Wong VW, Allison M, Tsochatzis E, Anstee QM, Sheridan DA, Eddowes PJ, Guha IN, Cobbold JF, Paradis V, Bedossa P, Miette V, Fournier-Poizat C, Sandrin L, Harrison SA, Harrison SA. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: A prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5(4):362–73. https://doi.org/10.1016/s2468-1253(19)30383-8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Niezen S, Trivedi HD, Mukamal KJ, Jiang ZG. Associations between alcohol consumption and hepatic steatosis in the USA. Liver Int. 2021;41(9):2020–3. https://doi.org/10.1111/liv.15020.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Unalp-Arida A, Ruhl CE. Transient elastography assessed hepatic steatosis and fibrosis are associated with body composition in the United States. Clin Gastroenterol Hepatol. 2020. https://doi.org/10.1101/2020.05.01.20087510.

    Article 

    Google Scholar
     

  • Petta S, Di Marco V, Pipitone RM, Grimaudo S, Buscemi C, Craxì A, Buscemi S. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: genetic and metabolic risk factors in a general population. Liver Int. 2018;38(11):2060–8. https://doi.org/10.1111/liv.13743.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–30. https://doi.org/10.1053/j.gastro.2019.01.042.

    Article 
    PubMed 

    Google Scholar
     

  • Ferraioli G, De Silvestri A, Lissandrin R, Maiocchi L, Tinelli C, Filice C, Barr R. Evaluation of inter-system variability in liver stiffness measurements. Ultraschall Medizin Eur J Ultrasound. 2018;40(01):64–75. https://doi.org/10.1055/s-0043-124184.

    Article 

    Google Scholar
     

  • Long MT, Massaro JM, Hoffmann U, Benjamin EJ, Naimi TS. Alcohol use is associated with hepatic steatosis among persons with presumed nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18(8):1831–41. https://doi.org/10.1016/j.cgh.2019.11.022.

    Article 
    PubMed 

    Google Scholar
     

  • Alkhouri N, Le P, Yang J, Sakkal C, Polanco P, Vos M, Noureddin M. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database. Oral Abstr Hepatol. 2021;74:1–156. https://doi.org/10.1002/hep.32187.

    Article 

    Google Scholar
     



  • Source link

    Back to top button